Table 1.
Correlation between RNASET2 protein expression and clinicopathologic features of GAC.
Clinicopathological features | All cases | RNASET2 protein expression | ||
---|---|---|---|---|
Negative | Positive (%) | p-valuea | ||
Age at diagnosis (years) | 0.559 | |||
≤ 56 | 76 | 52 | 24 (31.58%) | |
>56 | 92 | 59 | 33 (35.87%) | |
Gender | 0.491 | |||
Male | 109 | 70 | 39 (35.78%) | |
Female | 59 | 41 | 18 (30.51%) | |
Size (diameter), cmb | 0.182 | |||
<4 cm | 105 | 70 | 35 (33.33%) | |
≥4 cm | 52 | 38 | 14 (26.92%) | |
Depth of invasion | 0.312 | |||
T1a | 11 | 5 | 6 (54.54%) | |
T1b | 11 | 6 | 5 (45.45%) | |
T2 | 33 | 21 | 12 (36.36%) | |
T3/T4 | 113 | 79 | 34 (30.09%) | |
Nodal metastasis | 0.109 | |||
N0 | 57 | 33 | 24 (42.11%) | |
N1/N2/N3 | 111 | 78 | 33 (29.73%) | |
Differentiation | <0.001 | |||
Well/Moderately | 65 | 31 | 34 (52.31%) | |
Poorly/Undifferentiated | 103 | 80 | 23 (22.33%) |
Chi-square test.
11 cases were not included due to the discrepancy of tumor size.